Collection 2 (Sep 2021 - Aug 2022) Articles

Articles
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease
Takuya Hashimoto, Yoshiyasu Minami, Kiyoshi Asakura, et al.
Journal:
J Clin Lipidol

First published: December 3, 2021 DOI: 10.1016/j.jacl.2021.11.012
View
- Share
Articles
Cerebrovascular Disease and Statins
Beltrán Romero LM, Vallejo-Vaz AJ, Muñiz Grijalvo O
Journal:
Front Cardiovasc Med

First published: December 2, 2021 DOI: 10.3389/fcvm.2021.778740
View
- Share
Articles
Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
Thompson W, Morin L, Jarbøl DE, et al.
Journal:
JAMA Netw Open

First published: December 2, 2021 DOI: 10.1001/jamanetworkopen.2021.36802
View
- Share
Articles
Effectiveness of cascade testing strategies in relatives for familial hypercholesterolemia: A systematic review and meta-analysis
Leonardi-Bee J, Boateng C, Faria R, et al.
Journal:
Atherosclerosis

First published: December 1, 2021 DOI: 10.1016/j.atherosclerosis.2021.09.014
View
- Share
Articles
Prevalence and Significance of Risk Enhancing Biomarkers in the United States Population at Intermediate Risk for Atherosclerotic Disease; Risk Enhancing Factors in Intermediate Risk for ASCVD
Gloria L. Vega, Jijia Wang, Scott M. Grundy
Journal:
J Clin Lipidol

First published: November 30, 2021 DOI: 10.1016/j.jacl.2021.11.009
View
- Share
Articles
Statin Therapy in Very Old Patients: Lights and Shadows
Cobos-Palacios L, Sanz-Cánovas J, Muñoz-Ubeda M, et al.
Journal:
Front Cardiovasc Med

First published: November 29, 2021 DOI: 10.3389/fcvm.2021.779044
View
- Share
Articles
Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future
Catapano AL, Ray KK, Tokgözoglu L
Journal:
Atherosclerosis

First published: November 25, 2021 DOI: 10.1016/j.atherosclerosis.2021.11.021
View
- Share
Articles
Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content
Marston NA, Giugliano RP, Melloni GEM, et al.
Journal:
JAMA Cardiol

First published: November 13, 2021 DOI: 10.1001/jamacardio.2021.5083
View
- Share
Articles
Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort
Mortensen MB, Nordestgaard BG
Journal:
Lancet

First published: November 10, 2021 DOI: 10.1016/S0140-6736(20)32233-9
View
- Share
Articles
Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study
Sánchez-Ramos A, Fernández-Labandera C, Vallejo-Vaz AJ, et al.
Journal:
Atherosclerosis

First published: November 10, 2021 DOI: 10.1016/j.atherosclerosis.2021.11.007
View
- Share
Articles
Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction
McKinley EC, Bittner VA, Brown TM, et al.
Journal:
J Clin Lipidol

First published: November 7, 2021 DOI: 10.1016/j.jacl.2021.11.001
View
- Share
Articles
Familial Hypercholesterolemia: JACC Focus Seminar
Julia Brandts, Kausik K Ray
Journal:
Journal of the American College of Cardiology

First published: November 2, 2021 DOI: 10.1016/j.jacc.2021.09.004
View
- Share

1 … 9 10 11 12 13 14

Collection 2 (Sep 2021 - Aug 2022) Articles

Articles

Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease

Takuya Hashimoto, Yoshiyasu Minami, Kiyoshi Asakura, et al.

Articles

Cerebrovascular Disease and Statins

Beltrán Romero LM, Vallejo-Vaz AJ, Muñiz Grijalvo O

Articles

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark

Thompson W, Morin L, Jarbøl DE, et al.

Articles

Effectiveness of cascade testing strategies in relatives for familial hypercholesterolemia: A systematic review and meta-analysis

Leonardi-Bee J, Boateng C, Faria R, et al.

Articles

Prevalence and Significance of Risk Enhancing Biomarkers in the United States Population at Intermediate Risk for Atherosclerotic Disease; Risk Enhancing Factors in Intermediate Risk for ASCVD

Gloria L. Vega, Jijia Wang, Scott M. Grundy

Articles

Statin Therapy in Very Old Patients: Lights and Shadows

Cobos-Palacios L, Sanz-Cánovas J, Muñoz-Ubeda M, et al.

Articles

Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future

Catapano AL, Ray KK, Tokgözoglu L

Articles

Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content

Marston NA, Giugliano RP, Melloni GEM, et al.

Articles

Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort

Mortensen MB, Nordestgaard BG

Articles

Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study

Sánchez-Ramos A, Fernández-Labandera C, Vallejo-Vaz AJ, et al.

Articles

Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction

McKinley EC, Bittner VA, Brown TM, et al.

Articles

Familial Hypercholesterolemia: JACC Focus Seminar

Julia Brandts, Kausik K Ray

Articles

Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease

Takuya Hashimoto, Yoshiyasu Minami, Kiyoshi Asakura, et al.

Share

Articles

Cerebrovascular Disease and Statins

Beltrán Romero LM, Vallejo-Vaz AJ, Muñiz Grijalvo O

Share

Articles

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark

Thompson W, Morin L, Jarbøl DE, et al.

Share

Articles

Effectiveness of cascade testing strategies in relatives for familial hypercholesterolemia: A systematic review and meta-analysis

Leonardi-Bee J, Boateng C, Faria R, et al.

Share

Articles

Prevalence and Significance of Risk Enhancing Biomarkers in the United States Population at Intermediate Risk for Atherosclerotic Disease; Risk Enhancing Factors in Intermediate Risk for ASCVD

Gloria L. Vega, Jijia Wang, Scott M. Grundy

Share

Articles

Statin Therapy in Very Old Patients: Lights and Shadows

Cobos-Palacios L, Sanz-Cánovas J, Muñoz-Ubeda M, et al.

Share

Articles

Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future

Catapano AL, Ray KK, Tokgözoglu L

Share

Articles

Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content

Marston NA, Giugliano RP, Melloni GEM, et al.

Share

Articles

Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort

Mortensen MB, Nordestgaard BG

Share

Articles

Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study

Sánchez-Ramos A, Fernández-Labandera C, Vallejo-Vaz AJ, et al.

Share

Articles

Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction

McKinley EC, Bittner VA, Brown TM, et al.

Share

Articles

Familial Hypercholesterolemia: JACC Focus Seminar

Julia Brandts, Kausik K Ray

Share